PharmAla Launches Nexus Portal for MDMA Prescribers and Therapists
TORONTO, Oct. 08, 2025 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. ("PharmAla" or the "Company") (CSE: MDMA) (OTCQB:MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDX
(Financial Post, 2025-10-08T12:58:06Z)